Poor Neutralizing Antibody Responses in 132 Patients with CLL, NHL and HL after Vaccination against SARS-CoV-2: A Prospective Study.

Cancers (Basel) · 2021 · PMC8430746 · PMID 34503290

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In our cohort, humoral responses at day 22 and day 50 in the patient subgroup that received BTK inhibitors were lower compared to patients who received Rituximab-based or chemotherapy-only regimens, but the difference did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.